|
ZNF566 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.03580000132553E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.86519999947998E-07 |
| Normal-vs-Stage2 |
1.197480E-03 |
| Normal-vs-Stage3 |
2.90070000019682E-07 |
| Normal-vs-Stage4 |
6.22579999776107E-08 |
| Stage1-vs-Stage2 |
6.209800E-01 |
| Stage1-vs-Stage3 |
2.028400E-01 |
| Stage1-vs-Stage4 |
3.212400E-02 |
| Stage2-vs-Stage3 |
2.104200E-01 |
| Stage2-vs-Stage4 |
3.936500E-02 |
| Stage3-vs-Stage4 |
3.091000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92829999640298E-08 |
| Normal-vs-AfricanAmerican |
1.040820E-04 |
| Normal-vs-Asian |
4.773600E-04 |
| Caucasian-vs-AfricanAmerican |
3.435600E-01 |
| Caucasian-vs-Asian |
2.105800E-01 |
| AfricanAmerican-vs-Asian |
9.173700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.28530000001559E-06 |
| Normal-vs-Female |
1.37519999832136E-08 |
| Male-vs-Female |
5.910800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.6892000004608E-07 |
| Normal-vs-Age(41-60Yrs) |
3.75880000014206E-07 |
| Normal-vs-Age(61-80Yrs) |
8.88460000014746E-07 |
| Normal-vs-Age(81-100Yrs) |
1.285630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.613200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.454400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.982800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.148200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.913400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.535400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.186000E-04 |
| Classical-VS-Follicular |
1.011800E-01 |
| Classical-VS-Other |
7.322000E-01 |
| Classical-VS-Normal |
2.66130000003972E-06 |
| Tall-VS-Follicular |
7.150200E-02 |
| Tall-VS-Other |
2.329800E-01 |
| Tall-VS-Normal |
1.68060000360626E-08 |
| Follicular-VS-Other |
8.418000E-01 |
| Follicular-VS-Normal |
3.49969999979827E-07 |
| Other-VS-Normal |
5.441900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.39920000000282E-06 |
| Normal-vs-N1 |
2.15990000329569E-08 |
| N0-vs-N1 |
2.801800E-02 |
|
|
